BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh V, Md S, Alhakamy NA, Kesharwani P. Taxanes loaded polymersomes as an emerging polymeric nanocarrier for cancer therapy. European Polymer Journal 2022;162:110883. [DOI: 10.1016/j.eurpolymj.2021.110883] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Pei Q, Jiang B, Hao D, Xie Z. Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.02.021] [Reference Citation Analysis]
2 Parveen N, Abourehab MA, Shukla R, Thanikachalam PV, Jain GK, Kesharwani P. Immunoliposomes as an emerging nanocarrier for breast cancer therapy. European Polymer Journal 2023;184:111781. [DOI: 10.1016/j.eurpolymj.2022.111781] [Reference Citation Analysis]
3 Rehman U, Abourehab MA, Alexander A, Kesharwani P. Polymeric micelles assisted combinatorial therapy: Is it new hope for pancreatic cancer? European Polymer Journal 2023;184:111784. [DOI: 10.1016/j.eurpolymj.2022.111784] [Reference Citation Analysis]
4 Aziz A, Rehman U, Sheikh A, Abourehab MAS, Kesharwani P. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy. J Biomater Sci Polym Ed 2023;34:398-418. [PMID: 36083788 DOI: 10.1080/09205063.2022.2121592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Liu Z, Parveen N, Rehman U, Aziz A, Sheikh A, Abourehab MAS, Guo W, Huang J, Wang Z, Kesharwani P. Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer. Mol Cancer 2023;22:8. [PMID: 36635659 DOI: 10.1186/s12943-022-01696-5] [Reference Citation Analysis]
6 Rout SR, Kenguva G, Sharma D, Sahebkar A, Aeri V, Kesharwani P, Dandela R. Gene therapy using PLGA nanoparticles. Poly(Lactic-Co-glycolic Acid) (PLGA) Nanoparticles for Drug Delivery 2023. [DOI: 10.1016/b978-0-323-91215-0.00009-1] [Reference Citation Analysis]
7 Dey A, Kesharwani P, Dubey SK. Actively targeted nanoparticles in photodynamic therapy. Nanomaterials for Photodynamic Therapy 2023. [DOI: 10.1016/b978-0-323-85595-2.00014-1] [Reference Citation Analysis]
8 Giri L, Rout SR, Gowtham K, Abourehab MA, Kesharwani P, Dandela R. Biomimetic carbon nanotubes for neurological disease therapeutic. Emerging Applications of Carbon Nanotubes in Drug and Gene Delivery 2023. [DOI: 10.1016/b978-0-323-85199-2.00001-7] [Reference Citation Analysis]
9 Fatima M, Karwasra R, Almalki WH, Sahebkar A, Kesharwani P. Galactose engineered nanocarriers: Hopes and hypes in cancer therapy. European Polymer Journal 2022. [DOI: 10.1016/j.eurpolymj.2022.111759] [Reference Citation Analysis]
10 Degirmenci A, Ipek H, Sanyal R, Sanyal A. Cyclodextrin-containing redox-responsive nanogels: Fabrication of a modular targeted drug delivery system. European Polymer Journal 2022;181:111645. [DOI: 10.1016/j.eurpolymj.2022.111645] [Reference Citation Analysis]
11 Khan Z, Alhalmi A, Tyagi N, Khan WU, Sheikh A, Abourehab MAS, Kohli K, Kesharwani P. Folic acid engineered sulforaphane loaded microbeads for targeting breast cancer. Journal of Biomaterials Science, Polymer Edition 2022. [DOI: 10.1080/09205063.2022.2144692] [Reference Citation Analysis]
12 Musyuni P, Bai J, Sheikh A, Vasanthan KS, Jain GK, Abourehab MA, Lather V, Aggarwal G, Kesharwani P, Pandita D. Precision Medicine: Ray of Hope in Overcoming Cancer Multidrug Resistance. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100889] [Reference Citation Analysis]
13 Kailasam V, Cheruvu SS, Malani M, Sai Kameswari SM, Kesharwani P, Nirmal J. Recent advances in novel formulation approaches for tacrolimus delivery in treatment of various ocular diseases. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103945] [Reference Citation Analysis]
14 Fatima M, Abourehab MAS, Aggarwal G, Jain GK, Sahebkar A, Kesharwani P. Advancement of cell-penetrating peptides in combating triple-negative breast cancer. Drug Discov Today 2022;27:103353. [PMID: 36099963 DOI: 10.1016/j.drudis.2022.103353] [Reference Citation Analysis]
15 Singh V, Eljaaly K, Md S, Alhakamy NA, Kesharwani P. Triblock copolymeric drug delivery as an emerging nanocarrier for treatment of infectious diseases. Journal of Drug Delivery Science and Technology 2022;75:103691. [DOI: 10.1016/j.jddst.2022.103691] [Reference Citation Analysis]
16 Gupta P, Sheikh A, Abourehab MAS, Kesharwani P. Amelioration of Full-Thickness Wound Using Hesperidin Loaded Dendrimer-Based Hydrogel Bandages. Biosensors 2022;12:462. [DOI: 10.3390/bios12070462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Singh N, Handa M, Singh V, Kesharwani P, Shukla R. Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target 2022;:1-34. [PMID: 35722764 DOI: 10.1080/1061186X.2022.2092741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kumar Dubey S, Dabholkar N, Narayan Pal U, Singhvi G, Kumar Sharma N, Puri A, Kesharwani P. Emerging innovations in cold plasma therapy against cancer: a paradigm shift. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.05.014] [Reference Citation Analysis]
19 Nadaf A, Gupta A, Hasan N, Fauziya, Ahmad S, Kesharwani P, Ahmad FJ. Recent update on electrospinning and electrospun nanofibers: current trends and their applications. RSC Adv 2022;12:23808-28. [DOI: 10.1039/d2ra02864f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]